Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial-Reference-Cited by-同舟云学术

Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial

Published:2021-08 Issue:6 Volume:17 Page:474-480
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Zeymer Uwe,Leiva Orly,Hohnloser Stefan H.,Steg Philippe Gabriel,Oldgren Jonas,Nickenig Georg,Gabor Kiss Robert,Ongen Zeki,Navarro Estrada Jose,Oude Ophuis Ton,Lip Gregory Y.H.,Nordaby Matias,Miede Corinna,ten Berg Jurrien M.,Bhatt Deepak L.,Cannon Christopher P.

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention;Interventional Cardiology Clinics;2024-10

2. Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective;Interventional Cardiology: Reviews, Research, Resources;2023-02-17

3. P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCI;Reviews in Cardiovascular Medicine;2022-10-17

4. Post-PCI Antithrombotic Treatment With High Bleeding Risk;Journal of the American College of Cardiology;2022-09

5. The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention;Progress in Cardiovascular Diseases;2021-12